Aortic stenosis market seen reaching $16.17 billion by 2030
The global aortic stenosis market is projected to grow from $8.91 billion in 2025 to $10.06 billion in 2026, according to The Business Research Company. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region as TAVR, minimally invasive care and early detection gain traction.
Why it matters: - Aortic stenosis is a serious valve disease that can restrict blood flow and lead to heart failure if untreated. - Faster market growth points to rising demand for diagnosis, valve replacement procedures and less invasive treatment options. - The expansion reflects broader pressure on health systems as cardiovascular disease becomes more common and care moves toward earlier intervention.
What happened: - The Business Research Company published its Aortic Stenosis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on November 2, 2026. - The report values the aortic stenosis market at $8.91 billion in 2025 and projects $10.06 billion in 2026. - The report forecasts the market will reach $16.17 billion by 2030. - The report covers market segments, regional developments and leading competitors. - The company offers a free sample of the report here. - The company also provides the full report here.
The details: - The market is expected to grow at a 12.9% CAGR from 2025 to 2026. - The report projects a 12.6% CAGR through 2030. - Historic growth has been driven by an aging global population, more degenerative heart valve disease, more cardiac catheterization labs, advances in surgical valve replacement and greater clinical awareness of valvular disorders. - Future growth is tied to investment in next-generation valve technologies, wider use of transcatheter aortic valve replacement, outpatient cardiac care models, early intervention strategies and digital cardiac monitoring tools. - Key trends include minimally invasive cardiac interventions, improved diagnostic imaging, broader personalized valve therapy and earlier disease detection. - Aortic stenosis narrows the aortic valve, limiting blood flow from the left ventricle to the aorta and the rest of the body. - Common causes include age-related valve calcification, congenital valve defects and complications from rheumatic fever. - Untreated aortic stenosis can cause severe health complications, including heart failure. - Treatment options include medication and valve replacement surgery. - Rising heart disease prevalence is a major market driver. - Heart disease categories include coronary artery disease, heart failure, arrhythmias, valvular heart disease and cardiomyopathy. - Valve replacement and TAVR can improve cardiac function and lower the risk of serious cardiovascular outcomes. - In January 2025, the British Heart Foundation said about 7.6 million people in the UK live with heart and circulatory diseases. - The British Heart Foundation said those conditions account for about 27% of all UK deaths, more than 170,000 fatalities a year, or roughly 480 deaths daily. - The report says North America held the largest market share in 2025. - The report expects Asia-Pacific to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.
Between the lines: - The market outlook suggests a shift toward earlier diagnosis and less invasive procedures rather than late-stage intervention alone. - North America’s lead appears tied to advanced healthcare infrastructure and wider access to innovative treatments. - Asia-Pacific’s growth outlook points to rising healthcare investment and improving awareness of cardiovascular disease. - The report’s expanded 2026 coverage includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspots infographics.
What's next: - The next phase of growth will likely depend on how quickly healthcare systems adopt TAVR, digital monitoring and outpatient cardiac care. - Regional demand should continue to diverge, with mature markets leading adoption and faster-growing regions expanding access. - The report positions newer valve technologies and early detection as the main commercial and clinical themes to watch.
The bottom line: - Aortic stenosis is becoming a larger global market as aging populations, cardiovascular disease and minimally invasive treatments reshape care.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
The Asia Gazette
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.